2026-02-10 LIDR Meeting Notes
Edit

2026-02-10 LIDR Meeting Notes

Date

Feb 10, 2026

Attendees

Bolded names indicates attendance

 Name

Organization

 Name

Organization

Hung Luu

Children’s

Riki Merrick - regrets

Vernetzt, APHL

Andrea Pitkus

University of Wisconsin

Pam Banning

3M - Solventum

Xavier Gansel

Biomerieux

Amy McCormick

Epic

Dan Rutz

Epic

Rob Rae

CAP

Rob Hausam

Hausam Consulting

Stan Huff

University of Utah

Ed Heierman

Abbott / IICC

Carmen Pugh

long term lab professional

Laurent Lardin

Biomerieux

Ralf Herzog

Roche

Christina Gallegos

APHL

 

 

 

 

Follow up on UDI representation

Adding Conclusion here: UDI Background

Will keep filling this page out to collect all solutions there.

USCDI V7 Draft review

USCDI Draft-V7 Feedback

Specimen Collection Time

  • Suggest change to the definition: ”Clinically relevant time and/or date a care activity is performed.”

Add hierarchy to SNOMED for Specimen Type and Specimen Source for Applicable Standards

Revisit Use Cases for CDC submitted new data elements

AU solution to the “combine flag”

https://hl7v2wgau.atlassian.net/wiki/spaces/OOADRM20211/pages/721188/4+Observation+Reporting#4.13-Combining-tests-from-different-organisations

CDC work on postmarket surveillance

Might be able to add more columns to get “LIVD file content published like this one - example: Certified Total 25-hydroxyvitamin D Assays

LIDR Patterns

  • Biomerieux culture plates

  • Toxicology screening vs confirmatory

  • challenge tests

  • urine dipstick variations

  • required specimen pre-processing before running on instrument?

Action Item Follow up - Not discussed

Next call

Tuesday Feb 17, 2026 9 - 10 AM ET

Chat

 

Action items